CTLA4 and neoplasm: One approach to overcome tumor escape is the use of immune checkpoint inhibitors (ICIs) to block the inhibitory factors that hamper the host's immune response, such as CTLA‐4, programmed cell death protein 1 (PD‐1), and its ligand, PD‐L1.